Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dermatitis caused by estrogens]

D Coustou1, C Gautier, G Ducombs

  • 1Service de Dermatologie, Hôpital Pellegrin, CHU Bordeaux.

Annales De Dermatologie Et De Venereologie
|September 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children.

Annales de dermatologie et de venereologie·2025
Same author

Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis).

Annales de dermatologie et de venereologie·2024
Same author

Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper.

Allergy·2023
Same author

"SCULP" study: The benefits of skin graft pellets on the pain of sickle cell leg ulcers (SCLU).

Journal de medecine vasculaire·2023
Same author

Performance accuracy, advantages and limitations of a store-and-forward teledermatology platform developed for general practitioners: A retrospective study of 298 cases.

Annales de dermatologie et de venereologie·2022
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

This study details a rare case of estrogen sensitization causing cyclic skin reactions. Diagnosis involves skin and serum tests, with anti-estrogen treatment recommended for effective management.

Area of Science:

  • Dermatology
  • Endocrinology
  • Immunology

Background:

  • Hormone sensitization can manifest as autoimmune dermatitis.
  • Clinical presentations are often non-specific, but a cyclic pattern is suggestive.

Observation:

  • A 40-year-old woman presented with cyclic pruritus and skin lesions correlating with her menstrual cycle.
  • Contact dermatitis from an Estraderm patch was identified.
  • Positive prick and patch tests with estrone and positive serum tests for anti-ethinyl-estradiol and anti-progesterone antibodies were noted.

Findings:

  • Sensitization to estrogen and progesterone was confirmed through diagnostic testing.
  • The cyclic nature of the patient's symptoms strongly indicated hormone-induced dermatitis.
  • Skin and serum antibody tests aided in diagnosing hormone sensitization.

Related Experiment Videos

Implications:

  • Autoimmune dermatitis can be triggered by endogenous or exogenous sex hormones.
  • Accurate diagnosis relies on a combination of clinical presentation, skin tests, and laboratory results.
  • Treatment strategies include hormone inhibition or anti-estrogen therapy, with ovariectomy as a last resort.